BPA for duopa

Ended Awarded Last action

Contract number
36E79723A0024
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 100% complete
IDV ceiling
$12,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Abbvie US LLC, a subsidiary of the global biopharmaceutical company Abbvie Inc. The $12 million BPA is for the procurement of the Parkinson's disease medication DUOPA over a period of performance ending on July 31, 2025.

The BPA was established through the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract, enabling streamlined acquisition of this critical pharmaceutical product for use by federal healthcare agencies such as the Department of Veterans Affairs (VA) and Indian Health Service (IHS). The contract does not utilize any set-aside designations, indicating an open and competitive procurement process. This BPA represents one of several significant Indefinite Delivery/Indefinite Quantity (IDV) contracts held by Abbvie US LLC, demonstrating the company's strategic positioning as a reliable federal contractor for specialized medical supplies and pharmaceuticals.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00007 · Vyalev price change effective 6/1/2025 through the expiration of BPA 7/31/2025 $0
Legal Contract Cancellation P00006 · This modification is issued to cancel BPA 36E79723A0024 in its entirety. $0
Supplemental Agreement for work within scope P00004 · Product addition (vyalev) $0
Other Administrative Action P00005 · Update duopa ordering forms $0
Supplemental Agreement for work within scope P00003 · 2025 public law pricing updates $0
Exercise an Option P00002 · This modification is issued to exercise option year 1 on BPA 36E79723A0024. $0
Supplemental Agreement for work within scope P00001 · 2024 public law pricing updates $0
Original award $0

Quick answers

Who was awarded contract 36E79723A0024?

36E79723A0024 was awarded to Abbvie US LLC by National Acquisition Center (Headquarters) on November 1, 2023.

How much is contract 36E79723A0024 worth?

36E79723A0024's own ceiling is $12,000,000.

Who can order from contract 36E79723A0024?

36E79723A0024 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79723A0024 under another contract?

Yes. 36E79723A0024 is a blanket purchase agreement under 36F79718D0528, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79723A0024 competed?

The extent of competition for 36E79723A0024 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV